Here’s Why Aurora Cannabis (TSX:ACB) Stock Is a Bargain

Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB) stock looks like a nice discount priced in the single digits.

| More on:

Aurora Cannabis (TSX:ACB)(NYSE:ACB) stock has dropped 32.6% over the past three months as of close on August 29. Cannabis stocks have been hit with turbulence since the middle of spring, and Aurora has not been spared. Sales have disappointed in 2019 as we approach the one-year anniversary of the legalization of recreational cannabis. Canada is set to move forward with legalization of edibles in October of this year.

It has been a mixed bag for the top producers in earnings season. Aurora beat expectations with its third-quarter report in May. Revenue surged 363% year over year to $54.2 million. The company estimated that its recreational cannabis sales accounted for 20% of all consumer sales across the country.

Canada’s recreational roll-out has been plagued by several issues. Canadians have continued to buy cannabis from the black market, largely due to price advantages and availability. Populous provinces like Ontario and Quebec have failed to adequately expand the brick-and-mortar retail footprint, although supply issues have also hamstrung policy makers and the private sector.

Why Aurora is on my radar right now

This week, I’d discussed two cannabis stocks that looked oversold. Aurora stock had an RSI of 34 as of close on August 29. This puts shares just outside technically oversold territory.

Aurora brought investor Nelson Peltz on board as a strategic advisor back in March. There were hopes that this would facilitate a significant partnership in the near term. Canopy Growth’s big splash with Constellation Brands sparked a huge rally for the stock, but it has retreated and lengthened its time horizon to profitability. Aurora’s management has said that they are targeting multiple potential partnerships rather than one big fish.

In late August, the company announced the completion of its plan of arrangement with Hempco Food and Fibre. This grants Aurora access to low-cost, high-volume hemp material for the extraction of cannabidiol (CBD). CBD has exploded in popularity and offers nice growth in the attractive nutrition and supplements space.

Earlier in August, Aurora provided an update ahead of its fourth-quarter and full-year results for fiscal 2019. It is expected to release this earnings report on September 15. The company is projecting net revenues between $100 million and $107 million in the quarter, with total net revenues for the year in a range of $249 million to $256 million.

Aurora is set to post growth across its major segments, and it still expects production capacity to hit 150,000 kilograms annually by the end of 2019. Supply issues in Canada are expected to dissipate early next decade, and like other top producers, Aurora is turning its attention to international markets. The company and its subsidiaries are already active in 24 countries worldwide. The construction of its European production site, Aurora Nordic 2, will provide it with a promising footprint on a continent where the cannabis market is set to explode.

Shares of Aurora are still trading at the low end of its 52-week range. Cannabis has been throttled in the late spring and summer, but I expect the industry to bounce back in the near term. Aurora shares are well positioned to rebound with it.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ambrose O'Callaghan owns shares of Aurora Cannabis.

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Could the Cannabis Bubble Re-Inflate?

Let's dive into the question of whether the Canadian cannabis bubble can re-inflate from here.

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Should You Buy Canopy Growth Stock or Green Thumb Stock Today?

Let's dive into two cannabis giants, and which one may be the better pick for long-term investors.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Could Aurora Cannabis Stock Finally Recover by Year-End?

Down 99% from all-time highs, Aurora Cannabis stock is focused on improving profit margins and expanding sales of its medical…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Are Pot Stocks About to Surge Again? 

With pot stocks making big moves of late, many investors are now asking whether the cannabis sector is worth investing…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Pot Stocks Aurora Cannabis and Canopy Growth Bounce Back in Q4?

Down over 99% from all-time highs, Canadian pot stocks such as Aurora Cannabis and Canopy Growth remain high-risk bets.

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »